Expression and functional validation of new p38α transcriptional targets in tumorigenesis

Biochemical Journal

Volumn 434, Issue 3, 2011, Pages 549-558

  Swat, Aneta ^a   Dolado, Ignacio ^a   Igea, Ana ^b   Gomez Lopez, Gonzalo ^a   Pisano, David G ^a   Cuadrado, Ana ^a   Nebreda, Angel R ^a,b,c  

^a Structural Biology and Biocomputing Programme   (Spain)

^b INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Epidermal growth factor receptor (EGFR); Gene expression; p38 mitogen activated protein kinase (p38 MAPK); Ras oncogene; Tumorigenesis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; EMBRYO; GENE CONTROL; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENOME; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UNINDEXED SEQUENCE;

ANIMALS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION PROFILING; GENES, RAS; HUMANS; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE 14; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 79952221339     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20101410     Document Type: Article

References (67)

1. Cuenda, A. and Rousseau, S. (2007) p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim. Biophys. Acta 1773, 1358-1375
2. Cuadrado, A. and Nebreda, A. R. (2010) Mechanisms and functions of p38 MAPK signalling. Biochem. J. 429, 403-417
3. Bulavin, D. V. and Fornace, Jr, A. J. (2004) p38 MAP kinase's emerging role as a tumor suppressor. Adv. Cancer Res. 92, 95-118
4. Wagner, E. F. and Nebreda, A. R. (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9, 537-549
5. Crump, N. T., Han, Y. T. and Mahadevan, L. C. (2008) Stress-activated MAP kinases in chromatin and transcriptional complexes. Top. Curr. Genet. 20, 283-297
6. Perdiguero, E. and Munoz-Canoves, P. (2008) Transcriptional regulation by the p38 MAPK signaling pathway in mammalian cells. Top. Curr. Genet. 20, 51-79
7. Ambrosino, C., Iwata, T., Scafoglio, C., Mallardo, M., Klein, R. and Nebreda, A. R. (2006) TEF-1 and C/EBPβ are major p38α MAPK-regulated transcription factors in proliferating cardiomyocytes. Biochem. J. 396, 163-172
8. Adam, A. P., George, A., Schewe, D., Bragado, P., Iglesias, B. V., Ranganathan, A. C., Kourtidis, A., Conklin, D. S. and Aguirre-Ghiso, J. A. (2009) Computational identification of a p38SAPK-regulated transcription factor network required for tumor cell quiescence. Cancer Res. 69, 5664-5672
9. Ferreiro, I., Joaquin, M., Islam, A., Gomez-Lopez, G., Barragan, M., Lombardia, L., Dominguez, O., Pisano, D. G., Lopez-Bigas, N., Nebreda, A. R. and Posas, F. (2010) Whole genome analysis of p38 SAPK-mediated gene expression upon stress. BMC Genomics 11, 144
10. Lavoie, J. N., L'Allemain, G., Brunet, A., Muller, R. and Pouyssegur, J. (1996) Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271, 20608-20616
11. Bulavin, D. V., Phillips, C., Nannenga, B., Timofeev, O., Donehower, L. A., Anderson, C. W., Appella, E. and Fornace, Jr, A. J. (2004) Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat. Genet. 36, 343-350
12. Ventura, J. J., Tenbaum, S., Perdiguero, E., Huth, M., Guerra, C., Barbacid, M., Pasparakis, M. and Nebreda, A. R. (2007) p38α MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat. Genet. 39, 750-758
13. Alfonso, P., Dolado, I., Swat, A., Nunez, A., Cuadrado, A., Nebreda, A. R. and Casal, J. I. (2006) Proteomic analysis of p38α mitogen-activated protein kinase-regulated changes in membrane fractions of RAS-transformed fibroblasts. Proteomics 6 (Suppl. 1), S262-S271
14. Dolado, I., Swat, A., Ajenjo, N., De Vita, G., Cuadrado, A. and Nebreda, A. R. (2007) p38α MAP kinase as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell 11, 191-205
15. Swat, A., Dolado, I., Rojas, J. M. and Nebreda, A. R. (2009) Cell density-dependent inhibition of epidermal growth factor receptor signaling by p38α mitogen-activated protein kinase via Sprouty2 downregulation. Mol. Cell. Biol. 29, 3332-3343
16. Smyth, G.K., Michaud, J. and Scott, H. S. (2005) Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21, 2067-2075 (Pubitemid 40668046)
17. Jimeno, A., Tan, A. C., Coffa, J., Rajeshkumar, N. V., Kulesza, P., Rubio-Viqueira, B., Wheelhouse, J., Diosdado, B., Messersmith, W. A., Iacobuzio-Donahue, C. et al. (2008) Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer. Cancer Res. 68, 2841-2849 (Pubitemid 351556283)
18. Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S. and Mesirov, J. P. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102, 15545-15550
19. Ambrosino, C., Mace, G., Galban, S., Fritsch, C., Vintersten, K., Black, E., Gorospe, M. and Nebreda, A. R. (2003) Negative feedback regulation of MKK6 mRNA stability by p38α mitogen-activated protein kinase. Mol. Cell. Biol. 23, 370-381
20. Frey, M. R., Dise, R. S., Edelblum, K. L. and Polk, D. B. (2006) p38 kinase regulates epidermal growth factor receptor downregulation and cellular migration. EMBO J. 25, 5683-5692
21. Winograd-Katz, S. E. and Levitzki, A. (2006) Cisplatin induces PKB/Akt activation and p38(MAPK) phosphorylation of the EGF receptor. Oncogene 25, 7381-7390 (Pubitemid 44853429)
22. Zwang, Y. and Yarden, Y. (2006) p38 MAP kinase mediates stress-induced internalization of EGFR: implications for cancer chemotherapy. EMBO J. 25, 4195-4206 (Pubitemid 44435217)
23. Nicke, B., Bastien, J., Khanna, S. J., Warne, P. H., Cowling, V., Cook, S. J., Peters, G., Delpuech, O., Schulze, A., Berns, K. et al. (2005) Involvement of MINK, a Ste20 family kinase, in Ras oncogene-induced growth arrest in human ovarian surface epithelial cells. Mol. Cell 20, 673-685 (Pubitemid 41740690)
24. Dolado, I. and Nebreda, A. R. (2008) Regulation of tumorigenesis by p38α MAP kinase. Top. Curr. Genet. 20, 99-128
25. Gonzalez-Garcia, A., Pritchard, C. A., Paterson, H. F., Mavria, G., Stamp, G. and Marshall, C. J. (2005) RalGDS is required for tumor formation in a model of skin carcinogenesis. Cancer Cell 7, 219-226 (Pubitemid 40568681)
26. Bridgham, J. T. and Johnson, A. L. (2004) Alternatively spliced variants of Gallus gallus TNFRSF23 are expressed in the ovary and differentially regulated by cell signaling pathways. Biol. Reprod. 70, 972-979
27. Lee, S., Nakamura, E., Yang, H., Wei, W., Linggi, M. S., Sajan, M. P., Farese, R. V., Freeman, R. S., Carter, B. D., Kaelin, Jr, W. G. and Schlisio, S. (2005) Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell 8, 155-167
28. Khurana, A., Nakayama, K., Williams, S., Davis, R. J., Mustelin, T. and Ronai, Z. (2006) Regulation of the ring finger E3 ligase Siah2 by p38 MAPK. J. Biol. Chem. 281, 35316-35326
29. Kotlyarov, A. and Gaestel, M. (2007) Protein kinases as substrates for stress-activated protein kinases. Top. Curr. Genet. 20, 243-260
30. Tran Quang, C., Gautreau, A., Arpin, M. and Treisman, R. (2000) Ezrin function is required for ROCK-mediated fibroblast transformation by the Net and Dbl oncogenes. EMBO J. 19, 4565-4576
31. Tanoue, T. and Takeichi, M. (2004) Mammalian Fat1 cadherin regulates actin dynamics and cell-cell contact. J. Cell Biol. 165, 517-528 (Pubitemid 38679617)
32. Gangarosa, L.M., Sizemore, N., Graves-Deal, R., Oldham, S. M., Der, C. J. and Coffey, R. J. (1997) A raf-independent epidermal growth factor receptor autocrine loop is necessary for Ras transformation of rat intestinal epithelial cells. J. Biol. Chem. 272, 18926-18931
33. Sibilia, M., Fleischmann, A., Behrens, A., Stingl, L., Carroll, J., Watt, F. M., Schlessinger, J. and Wagner, E. F. (2000) The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development. Cell 102, 211-220
34. Overall, C. M. and Dean, R. A. (2006) Degradomics: systems biology of the protease web. Pleiotropic roles of MMPs in cancer. Cancer Metastasis Rev. 25, 69-75
35. Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., Leake, D., Godden, E. L., Albertson, D. G., Nieto, M. A. et al. (2005) Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436, 123-127 (Pubitemid 40966197)
36. Sternlicht, M. D., Lochter, A., Sympson, C. J., Huey, B., Rougier, J. P., Gray, J. W., Pinkel, D., Bissell, M. J. and Werb, Z. (1999) The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98, 137-146 (Pubitemid 29344902)
37. Imhof, I., Gasper, W. J. and Derynck, R. (2008) Association of tetraspanin CD9 with transmembrane TGFα confers alterations in cell-surface presentation of TGFα and cytoskeletal organization. J. Cell Sci. 121, 2265-2274
38. Shi, W., Fan, H., Shum, L. and Derynck, R. (2000) The tetraspanin CD9 associates with transmembrane TGF-α and regulates TGF-α-induced EGF receptor activation and cell proliferation. J. Cell Biol. 148, 591-602
39. Fabbretti, E., Edomi, P., Brancolini, C. and Schneider, C. (1995) Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A. Genes Dev. 9, 1846-1856
40. Zoidl, G., Blass-Kampmann, S., D'Urso, D., Schmalenbach, C. and Muller, H. W. (1995) Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth. EMBO J. 14, 1122-1128
41. Frese, S., Schubert, W. D., Findeis, A. C., Marquardt, T., Roske, Y. S., Stradal, T. E. and Heinz, D. W. (2006) The phosphotyrosine peptide binding specificity of Nck1 and Nck2 Src homology 2 domains. J. Biol. Chem. 281, 18236-18245
42. Li, W., Hu, P., Skolnik, E. Y., Ullrich, A. and Schlessinger, J. (1992) The SH2 and SH3 domain-containing Nck protein is oncogenic and a common target for phosphorylation by different surface receptors. Mol. Cell. Biol. 12, 5824-5833
43. Ruusala, A., Pawson, T., Heldin, C. H. and Aspenstrom, P. (2008) Nck adapters are involved in the formation of dorsal ruffles, cell migration, and Rho signaling downstream of the platelet-derived growth factor β receptor. J. Biol. Chem. 283, 30034-30044
44. Oertle, T., Merkler, D. and Schwab, M. E. (2003) Do cancer cells die because of Nogo-B? Oncogene 22, 1390-1399
45. Cho, S. G., Lee, Y. H., Park, H. S., Ryoo, K., Kang, K. W., Park, J., Eom, S. J., Kim, M. J., Chang, T. S., Choi, S. Y. et al. (2001) Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J. Biol. Chem. 276, 12749-12755
46. Zhou, S. G., Wang, P., Pi, R. B., Gao, J., Fu, J. J., Fang, J., Qin, J., Zhang, H. J., Li, R. F., Chen, S. R. et al. (2008) Reduced expression of GSTM2 and increased oxidative stress in spontaneously hypertensive rat. Mol. Cell. Biochem. 309, 99-107
47. Schweiger, A., Christensen, I. J., Nielsen, H. J., Sorensen, S., Brunner, N. and Kos, J. (2004) Serum cathepsin Has a potential prognostic marker in patients with colorectal cancer. Int. J. Biol. Markers 19, 289-294
48. Zhang, J., Kalyankrishna, S., Wislez, M., Thilaganathan, N., Saigal, B., Wei, W., Ma, L., Wistuba, II, Johnson, F. M. and Kurie, J. M. (2007) SRC-family kinases are activated in non-small cell lung cancer and promote the survival of epidermal growth factor receptor-dependent cell lines. Am. J. Pathol. 170, 366-376
49. Castillo, J., Erroba, E., Perugorria, M. J., Santamaria, M., Lee, D. C., Prieto, J., Avila, M. A. and Berasain, C. (2006) Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells. Cancer Res. 66, 6129-6138
50. Fujiwara, Y., Sugita, Y., Nakamori, S., Miyamoto, A., Shiozaki, K., Nagano, H., Sakon, M. and Monden, M. (2000) Assessment of Stanniocalcin-1 mRNA as a molecular marker for micrometastases of various human cancers. Int. J. Oncol. 16, 799-804
51. Yang, Y., Goldstein, B. G., Nakagawa, H. and Katz, J. P. (2007) Kruppel-like factor 5 activates MEK/ERK signaling via EGFR in primary squamous epithelial cells. FASEB J. 21, 543-550 (Pubitemid 46213501)
52. Matoskova, B., Wong, W. T., Salcini, A. E., Pelicci, P. G. and Di Fiore, P. P. (1995) Constitutive phosphorylation of eps8 in tumor cell lines: relevance to malignant transformation. Mol. Cell. Biol. 15, 3805-3812
53. Stewart, J. R. and O'Brian, C. A. (2005) Protein kinase C-α mediates epidermal growth factor receptor transactivation in human prostate cancer cells. Mol. Cancer Ther. 4, 726-732
54. Wang, Y., Du, D., Fang, L., Yang, G., Zhang, C., Zeng, R., Ullrich, A., Lottspeich, F. and Chen, Z. (2006) Tyrosine phosphorylated Par3 regulates epithelial tight junction assembly promoted by EGFR signaling. EMBO J. 25, 5058-5070 (Pubitemid 44658524)
55. Nie, Z., Hirsch, D. S., Luo, R., Jian, X., Stauffer, S., Cremesti, A., Andrade, J., Lebowitz, J., Marino, M., Ahvazi, B. et al. (2006) A BAR domain in the N terminus of the Arf GAP ASAP1 affects membrane structure and trafficking of epidermal growth factor receptor. Curr. Biol. 16, 130-139
56. Hehlgans, S., Haase, M. and Cordes, N. (2007) Signalling via integrins: implications for cell survival and anticancer strategies. Biochim. Biophys. Acta 1775, 163-180
57. Reinheckel, T., Hagemann, S., Dollwet-Mack, S., Martinez, E., Lohmuller, T., Zlatkovic, G., Tobin, D. J., Maas-Szabowski, N. and Peters, C. (2005) The lysosomal cysteine protease cathepsin L regulates keratinocyte proliferation by control of growth factor recycling. J. Cell Sci. 118, 3387-3395 (Pubitemid 41246094)
58. Hirsch, D. S. and Wu, W. J. (2007) Cdc42: an effector and regulator of ErbB1 as a strategic target in breast cancer therapy. Expert Rev. Anticancer Ther. 7, 147-157
59. Radke, S., Austermann, J., Russo-Marie, F., Gerke, V. and Rescher, U. (2004) Specific association of annexin 1 with plasma membrane-resident and internalized EGF receptors mediated through the protein core domain. FEBS Lett. 578, 95-98 (Pubitemid 39576107)
60. Warren, R. A., Green, F. A., Stenberg, P. E. and Enns, C. A. (1998) Distinct saturable pathways for the endocytosis of different tyrosine motifs. J. Biol. Chem. 273, 17056-17063
61. Uttamsingh, S., Bao, X., Nguyen, K. T., Bhanot, M., Gong, J., Chan, J. L., Liu, F., Chu, T. T. and Wang, L. H. (2008) Synergistic effect between EGF and TGF-β1 in inducing oncogenic properties of intestinal epithelial cells. Oncogene 27, 2626-2634
62. Wolthuis, R. M., Zwartkruis, F., Moen, T. C. and Bos, J. L. (1998) Ras-dependent activation of the small GTPase Ral. Cur Biol. 8, 471-474
63. Henderson, G. S., van Diest, P. J., Burger, H., Russo, J. and Raman, V. (2006) Expression pattern of a homeotic gene, HOXA5, in normal breast and in breast tumors. Cell. Oncol. 28, 305-313
64. Miller, W. E., Cheshire, J. L. and Raab-Traub, N. (1998) Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression. Mol. Cell. Biol. 18, 2835-2844
65. Herrlich, A., Leitch, V. and King, L. S. (2004) Role of proneuregulin 1 cleavage and human epidermal growth factor receptor activation in hypertonic aquaporin induction. Proc. Natl. Acad. Sci. U.S.A. 101, 15799-15804
66. Bianco, A., Poukkula, M., Cliffe, A., Mathieu, J., Luque, C. M., Fulga, T. A. and Rorth, P. (2007) Two distinct modes of guidance signalling during collective migration of border cells. Nature 448, 362-365 (Pubitemid 47080343)
67. Ueda, S., Basaki, Y., Yoshie, M., Ogawa, K., Sakisaka, S., Kuwano, M. and Ono, M. (2006) PTEN/Akt signaling through epidermal growth factor receptor is prerequisite for angiogenesis by hepatocellular carcinoma cells that is susceptible to inhibition by gefitinib. Cancer Res. 66, 5346-5353 (Pubitemid 43844960)